George Migausky

George V.
Migausky currently serves as Independent Director at REGENXBIO, Inc. since 2021, Director at Immunovant Sciences Ltd. since 2020, and Trustee at Massachusetts Eye & Ear Infirmary, Inc. since 2015.
Former roles include Independent Director at Abeona Therapeutics, Inc. in 2020, Independent Director at Immunovant, Inc. from 2019 to 2025, Independent Director at Dimension Therapeutics, Inc. from 2015 to 2017, Director at Rocket Pharmaceuticals, Inc., Director at Health Sciences Acquisitions Corp., Director at Immunovant, Inc., Independent Director at Hyperion Catalysis International, Inc. from 2008 to 2022, Chief Financial Officer & Executive Vice President at Dyax Corp.
from 2010 to 2016, Chief Financial Officer & Vice President at BioVeris Corp.
from 1986 to 2007, Chief Financial Officer at Ocular Therapeutix, Inc. in 2017, Chief Financial Officer & Vice President at IGEN International, Inc. from 1986 to 2004, Manager at Deloitte & Touche, and Chief Financial Officer at Wellstat Management Co. LLC.
from 2007 to 2008.
Education includes an MBA from Babson College and an undergraduate degree from Boston College conferred in 1976.